GE HealthCare Technologies Inc. (GEHC): debt financing — GE HealthCare enters new $0.5B 364-day revolving credit facility, replacing prior facility

GE HealthCare Technologies Inc.

New $0.5B senior unsecured 364-day revolver matures February 25, 2027; replaces similarly sized 2025 facility terminated without penalty.
Interest rate options include ABR, daily simple SOFR, adjusted Term SOFR for USD; EURIBOR for EUR; SONIA for GBP; margin tied to credit ratings.
Covenants limit liens, fundamental changes, leverage ratio, and subsidiary indebtedness; standard events of default included.
JPMorgan Chase Bank serves as administrative agent; joint bookrunners include Citibank, BofA Securities, BNP Paribas, Goldman Sachs, Morgan Stanley.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

GE HealthCare Technologies Inc. incurred revolving credit of $0.5 billion with JPMorgan Chase Bank, N.A., as administrative agent at alternate base rate, a daily simple SOFR rate, or an adjusted Term SOFR rate for maturing February 25, 2027.

Instrument: revolving credit
Principal: $0.5 billion
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Rate: alternate base rate, a daily simple SOFR rate, or an adjusted Term SOFR rate for
Maturity: February 25, 2027
Event: incurrence

Exact text from the filing

On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GE HealthCare Technologies Inc. entered into New Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

Action: entry
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A. and the lenders named therein
Value: $0.5 billion
Effective: 2026-02-26

Exact text from the filing

On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GE HealthCare Technologies Inc. terminated 2025 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

Action: termination
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A. and the lenders named therein
Value: $0.5 billion
Effective: 2026-02-26

Exact text from the filing

In connection with the Company’s entry into the New Revolving Credit Agreement, the 2025 364-Day Revolving Credit Agreement, which provided for a $0.5 billion 364-day senior unsecured revolving credit facility, was terminated without penalty on February 26, 2026.

View on SEC.gov

Browse all debt financings →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-26-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.